The Brazilian Senate recently approved significant legislative reforms, setting the stage for a considerable advancement in pharmaceutical clinical research. These regulations aim to attract investments totaling 5 billion reais (approximately $1 billion). Consequently, Brazil anticipates a new era of medical innovation. The bill, which reinforces the National System of Ethics in Clinical Research with Human […]
